An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling
Pathological Gambling
About this trial
This is an interventional treatment trial for Pathological Gambling focused on measuring Gambling, Gambler, Gamble, Pathological
Eligibility Criteria
Inclusion Criteria: Men and women age 18-65 Current DSM-IV PG Exclusion Criteria: Unstable medical illness on physical examination History of seizures Myocardial infarction within 6 months Current pregnancy or lactation, or inadequate contraception in women of childbearing potential Clinically significant suicidality Lifetime history of DSM-IV bipolar disorder type I, dementia, or schizophrenia or any other DSM-IV psychotic disorder Current or recent (past 3 months) DSM-IV substance abuse or dependence Illegal substance within 2 weeks of study initiation Initiation of psychotherapy or behavior therapy from a mental health professional within 3 months prior to study baseline Previous treatment with N-Acetyl Cysteine
Sites / Locations
- University of Minnesota